Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is -100.00% vs 60.00% in Mar 2025
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2026 is 0.00% vs -100.00% in Mar 2025
Investments
YoY Growth in year ended Mar 2026 is 13.48% vs 3,401.64% in Mar 2025
Current Assets
YoY Growth in year ended Mar 2026 is -39.86% vs 5,720.00% in Mar 2025
Compare Balance Sheet Results of Bacil Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
13.97
185.90
-171.93
-92.49%
Share Warrants & Outstandings
Total Reserve
10.84
22.57
-11.73
-51.97%
Shareholder's Funds
24.81
208.46
-183.65
-88.10%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.00
0.00
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
-0.62
0.00
-0.62
0.00%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
-0.62
212.75
-213.37
-100.29%
Current Liabilities
Trade Payables
0.02
195.02
-195.00
-99.99%
Other Current Liabilities
0.18
35.72
-35.54
-99.50%
Short Term Borrowings
0.00
0.00
0.00
0.00%
Short Term Provisions
2.38
0.00
2.38
0.00%
Total Current Liabilities
2.58
230.74
-228.16
-98.88%
Total Liabilities
26.77
651.96
-625.19
-95.89%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
0.00
0.01
-0.01
-100.00%
Less: Accumulated Depreciation
0.00
0.00
0.00
0.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.00
0.00
0.00
0.00%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
24.24
0.00
24.24
0.00%
Long Term Loans & Advances
0.78
0.00
0.78
0.00%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
25.02
0.00
25.02
0.00%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
0.00
1.58
-1.58
-100.00%
Sundry Debtors
1.18
252.19
-251.01
-99.53%
Cash and Bank
0.57
46.57
-46.00
-98.78%
Other Current Assets
0.00
0.00
0.00
0.00%
Short Term Loans and Advances
0.00
351.61
-351.61
-100.00%
Total Current Assets
1.75
651.96
-650.21
-99.73%
Net Current Assets (Including Current Investments)
-0.83
421.21
-422.04
-100.20%
Total Current Assets Excluding Current Investments
1.75
651.96
-650.21
-99.73%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
26.77
651.96
-625.19
-95.89%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
0.00
212.75
-212.75
-100.00%
Book Value per share (adjusted)
17.76
1.02
16.74
1,641.18%
Annual - Borrowings
Borrowings 0.00 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -100.00% vs 60.00% in Mar 2025
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 0.00 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 0.00% vs -100.00% in Mar 2025
Annual - Investments
Investments 24.24 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 13.48% vs 3,401.64% in Mar 2025
Annual - Current Assets
Current Assets 1.75 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -39.86% vs 5,720.00% in Mar 2025
